EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC 3.0

IRIS without PML in MS patients – a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature

Anna Jamroz-Wiśniewska, Anna Drelich-Zbroja, Urszula Chyrchel-Paszkiewicz, Konrad Rejdak

Annals of Agricultural and Environmental Medicine · 2025

DOI: 10.26444/aaem/200751 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Agricultural and Environmental Medicine, 2025. Verfasst von Anna Jamroz-Wiśniewska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University, Lublin, Poland. Hauptthemen laut MEDLINE: Immune Reconstitution Inflammatory Syndrome, Alemtuzumab, Cladribine, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Reconstitution Inflammatory SyndromeAlemtuzumabCladribineMultiple Sclerosis, Relapsing-RemittingImmunosuppressive AgentsMultiple SclerosisHumansAdultMale

Stichwörter der Autor:innen

alemtuzumabhighly-active multiple sclerosisimmune reconstitution inflammatory syndrome (IRIS)oral cladribine

Substanzen

AlemtuzumabCladribineImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Neurology, Medical University, Lublin, Poland.
  • Interventional Radiology and Neuroradiology, Medical University, Lublin, Poland.

Zitieren

APA

Jamroz-Wiśniewska, A., Drelich-Zbroja, A., Chyrchel-Paszkiewicz, U., & Rejdak, K. (2025). IRIS without PML in MS patients – a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature. Annals of Agricultural and Environmental Medicine. https://doi.org/10.26444/aaem/200751

Vancouver

Jamroz-Wiśniewska A, Drelich-Zbroja A, Chyrchel-Paszkiewicz U, Rejdak K. IRIS without PML in MS patients – a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature. Annals of Agricultural and Environmental Medicine. 2025. doi:10.26444/aaem/200751

BibTeX
@article{JamrozWiniewska2025,
  author = {Jamroz-Wiśniewska, Anna and Drelich-Zbroja, Anna and Chyrchel-Paszkiewicz, Urszula and Rejdak, Konrad},
  title = {IRIS without PML in MS patients – a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature},
  journal = {Annals of Agricultural and Environmental Medicine},
  year = {2025},
  doi = {10.26444/aaem/200751}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche